tirzepatide doctor philly Empowering Patients Mounjaro for weight loss in

We're talking days, not weeks or months

However, neither DIRECT nor DPP reported on the preventive outcomes of patients who did not reduce body weight but achieved remission

The FDA label notes that gastrointestinal adverse reactions occur more frequently during dose escalation

The honest answer is that its highly individual

The first time we saw this was during the liraglutide trials where blood pressure reduction occurred within 2 weeks of initiation of therapy, which was before any meaningful weight benefit was demonstrated suggesting that weight loss is not the driver of the blood pressure benefits

In a randomized controlled trial, the GLP-1R agonist exenatide showed reduced alcohol intake in a subgroup of people with both obesity and alcohol use disorder